Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation (EW)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
86. 60
-1.5
-1.7026%
$
48.42B Market Cap
32.12 P/E Ratio
- Div Yield
4.01M Volume
2.51 Eps
$ 88.1
Previous Close
Add Transaction
Day Range
86.08 88.36
Year Range
72.67 96.29
Want to track EW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Edwards Lifesciences Corporation (EW) Statistics

Valuation metrics

Market Cap 48.42B
Enterprise value 46.86B
Trailing P/E (ttm) 48.97
Forward P/E 24.74
PEG ratio -0.65
Price/Sales (ttm) 7.53
Price/Book (mrq) 4.63
Enterprise Value/Revenue 7.2
Enterprise Value/EBITDA 29.61

Overview

Shares outstanding 580.7M
Float 579.03M
Shares short 12.38M
% Held by insiders 0.01%
% Held by institutions 0.92%
Average volume (10 days) 3.89M
Average volume (90 days) 3.9M

Price summary

52-Week low 72.67
52-Week high 96.29
Beta 0.93
50-Day moving average 87.56
200-Day moving average 83.92

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 1 Jun 2020

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.15%
Operating margin 0.28%

Operational effectiveness

Return on assets 0.07%
Return on equity 0.1%

Income Statement

Revenue (ttm) 6.07B
Revenue per share (ttm) 11.3
Quarterly revenue growth (yoy) 0.13%
Gross profit (ttm) 4.73B
EBITDA 1.96B
Net income to common (ttm) 1.06B
Diluted EPS (ttm) 1.74
Quarterly earnings growth (yoy) -0.76%

Balance Sheet

Total cash (mrq) 4.23B
Total cash per share (mrq) 7.38
Total debt (mrq) 705.4M
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 4.52%
Book value per share (mrq) 18.61

Cash Flow

Cash flow statement 1.6B
Levered free cash flow (LFCF) 1.17B